We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $4 · 1 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Marchex Inc. (MCHX) Shows Modest Recovery, Breaks Above Key Support Level - IV Percentile - thelegaladvocate.com
Marchex Inc. (MCHX) Shows Modest Recovery, Breaks Above Key Support Level - IV Percentile thelegaladvocate.com
Marchex Inc. (MCHX) Q1 2026 Earnings: EPS Miss Highlights Ongoing Challenges Amid Revenue Disclosures - thelegaladvocate.com
Marchex Inc. (MCHX) Q1 2026 Earnings: EPS Miss Highlights Ongoing Challenges Amid Revenue Disclosures thelegaladvocate.com
Marchex (NASDAQ: MCHX) to buy Archenia; $10M notes and 2M‑share earn‑outs - Stock Titan
Marchex (NASDAQ: MCHX) to buy Archenia; $10M notes and 2M‑share earn‑outs Stock Titan
Northland Securities Maintains Marchex(MCHX.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Northland Securities Maintains Marchex(MCHX.US) With Buy Rating, Maintains Target Price $4 Moomoo
Marchex (MCHX) Q1 2026 Earnings: EPS Falls Short of Consensus in Challenging Quarter - Dividend Earnings Report - thelegaladvocate.com
Marchex (MCHX) Q1 2026 Earnings: EPS Falls Short of Consensus in Challenging Quarter - Dividend Earnings Report thelegaladvocate.com
Marchex (MCHX) Edges Higher as Shares Test Key Resistance Near $1.76 - Watchlist Stock Ideas - thelegaladvocate.com
Marchex (MCHX) Edges Higher as Shares Test Key Resistance Near $1.76 - Watchlist Stock Ideas thelegaladvocate.com
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 11. | After market close (AMC) | $0.02 | — | — | $11.19M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.05 | — | — | $11.4M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.07 | — | — | $36.2M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.05 | — | — | $23.65M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2021. 12. 29. | Roth Capital | — | Maintain | — → Buy | — | Roth Capital: Buy |
| 2019. 01. 28. | Roth Capital | — | Upgrade | Neutral → Buy | — | Roth Capital: Neutral → Buy |
Compare a firm's past rating changes and its actions on other stocks in the same sector.
As of FY2026Q1 · Source: SEC/DART + price data
Filings, earnings, and institutional changes summarized in one paragraph, with source links.
No holdings data to show.
See new positions, full exits, and weight changes.